Holen Sie sich die Stockscreener-App
1.54
4.05%
0.06
Handel nachbörslich:
1.54
Alector Inc Aktie (ALEC) Neueste Nachrichten
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Share Price HigherPretax Income Report - newsline.com
This Insider Has Just Sold Shares In Alector - simplywall.st
Alector Inc. (ALEC) Q1 2026 Earnings: Narrower-Than-Expected Loss Exceeds Estimates; Stock Gains Nearly 2%Pretax Income Report - newsline.com
[Form 4] Alector, Inc. Insider Trading Activity - Stock Titan
Alector (ALEC) CEO sells shares to cover RSU tax obligations - Stock Titan
Alector (ALEC) CFO Berkley sells shares to cover RSU tax obligations - Stock Titan
ALEC (NASDAQ: ALEC) Form 144 lists 3,475 restricted common shares - Stock Titan
Alector (NASDAQ: ALEC) Rule 144 notice lists RSU vesting and stock sales - Stock Titan
Alector (NASDAQ: ALEC) files to sell 132,805 RSU shares after vesting - Stock Titan
Alector halts mid-stage trial for Alzheimer’s candidate developed with GSK - MSN
ALEC Q1 2026 Earnings: Narrower Loss Surprises as Pipeline Progress Highlights Biotech ResilienceGuidance vs Actual - newsline.com
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Progress in Neurodegenerative Pipeline - The Legal Advocate
Alector Shares Up, Focus Turns to Pipeline After Setback - Bez Kabli
ALEC Q1 2026 Earnings: EPS Surprises with 39.95% Beat as Pipeline AdvancesInvestor Earnings Call - The Legal Advocate
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Surprises, No Revenue YetQuarterly Earnings - thelegaladvocate.com
Alector Inc. (ALEC) Holds Steady at $2.21 as Key Support and Resistance Levels Come into FocusOrder Block - The Legal Advocate
Number of shareholders of Alector, Inc. – DUS:0Z2 - TradingView
Alector Inc. (ALEC) Shows Resilience: Shares Up 4.25% as Biotech Sector Watches Key LevelsCalendar Spread Trade - The Legal Advocate
How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus - Yahoo Finance
Alector (ALEC) Q1 2026 Earnings Beat: Revenue $N/A, EPS $-0.21High Attention Stocks - Newser
Should You Sell Alector (ALEC) After -2.83% Drop? 2026-05-15Breakout Confirmation - newsline.com
Polaris entities hold 4.85M ALEC shares (ALEC) — Amendment No.7 - Stock Titan
MSN - MSN
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alector (ALEC), Spyre Therapeutics (SYRE) and Perspective Therapeutics (CATX) - The Globe and Mail
TradingKey - TradingKey
Alector Establishes $125 Million At-the-Market Offering - The Globe and Mail
Myles Minter Reiterates Hold on Alector as Late-Stage Trial Failures Trigger Pipeline Reset but Next-Gen Brain Carrier Platform Offers Long-Term Optionality - TipRanks
Alector (ALEC) Reports Q1 Revenue Shortfall Amidst Strategic Dev - GuruFocus
Alector, Inc. Announces $125 Million Common Stock Sales Agreement with TD Securities (USA) LLC - Minichart
Alector: Q1 Earnings Snapshot - theheraldreview.com
Why Alector (ALEC) is a smarter play than most realize (Smart Money Outflows) 2026-05-08Wave Equality - newsline.com
Alector posts first quarter 2026 financial results amid new business updates - Traders Union
Alector : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Alector (NASDAQ: ALEC) establishes $125M stock ATM facility - Stock Titan
Alector (NASDAQ: ALEC) files $125M ATM offering with TD Cowen - Stock Titan
Alector (NASDAQ: ALEC) narrows Q1 2026 loss as it refocuses pipeline - Stock Titan
Alector Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Alector | 10-Q: Q1 2026 Earnings Report - Moomoo
Alector | 8-K: Alector Reports First Quarter 2026 Financial Results and Provides Business Update - Moomoo
Alector (NASDAQ: ALEC) Q1 2026 results, trial halt and ABC focus - Stock Titan
BRIEF-Alector Q1 Basic EPS USD -0.21 - TradingView
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
MSN Money - MSN
Transcript : Alector, Inc.Special Call - marketscreener.com
Alector Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Morgan Stanley Maintains Alector(ALEC.US) With Sell Rating, Raises Target Price to $2 - Moomoo
Five-Way Obesity Drug Shows Effectiveness in Mice; Alector Stops Alzheimer’s Trial - geneonline.com
Franklin Lexington Private Markets Fund's Alector Inc(ALEC) Holding History - GuruFocus
Morgan Stanley raises Alector stock price target on pipeline focus By Investing.com - Investing.com Australia
Morgan Stanley raises Alector stock price target on pipeline focus - Investing.com
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):